Chapter 1. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET– By Component

6.1. Tags

6.2. Readers

6.3. Middleware

6.4. Services

Chapter 7. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET– By Application

7.1. Drug Tracking

7.2. Drug Authentication

7.3. Inventory Management

7.4. Others

Chapter 8. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET– By End User

8.1. Pharmaceutical Manufacturers

8.2. Healthcare Providers

8.3. Others

Chapter 9. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. RFID IN PHARMACEUTICALS OPPORTUNITY ASSESSMENT MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10